98
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Synergistic Activity of Cyclo(phe-pro) Antibiotic from Streptomyces violascens VS in Reducing the Drug Resistance Burden of Clinically Significant Pathogens

&
Pages 450-460 | Received 08 Dec 2022, Accepted 14 Dec 2022, Published online: 11 Jan 2023

References

  • Mitchell, J., O’Neill, A.J. and King, R. (2022). Creating a framework to align antimicrobial resistance (AMR) research with the global guidance: a viewpoint. The Journal of Antimicrobial Chemotherapy. 77(9): 2315-2320. doi: 10.1093/jac/dkac205
  • Sun, D., Jeannot, K., Xiao, Y. and Knapp, C. W. (2019). Editorial: Horizontal Gene Transfer Mediated Bacterial Antibiotic Resistance. Frontiers in Microbiology. 10: Article 1933.
  • Breijyeh, Z., Jubeh, B. and Karaman, R. (2020). Resistance of Gram-Negative Bacteria to Current Antibacterial Agents and Approaches to Resolve It. Molecules (Basel, Switzerland). 25(6): 1340. doi: 10.3390/molecules25061340
  • Fenta, F., Alemu, D. and Alelign, D. (2022). Magnitude of Drug-Resistant Gram-Positive Bacterial Pathogens, and Its Associated Factors from External Ocular Infected Patients Attending at Jinka General Hospital Ophthalmic Clinic, Southern Ethiopia. Infection and Drug Resistance, 15, 947-959. doi: 10.2147/IDR.S356974
  • Pang, Z., Raudonis, R., Glick, B.R., Lin, T.J. and Cheng, Z. (2019). Antibiotic resistance in Pseudomonas aeruginosa: mechanisms and alternative therapeutic strategies. Biotechnology Advances. 37(1): 177-192. doi: 10.1016/j.biotechadv.2018.11.013
  • Guo, J., Shi, J., Wang, H., Chen, H., Liu, S., Li, J. and Wang, Y. (2019). Emerging Gram-positive bacteria and drug resistance in cirrhosis patients with spontaneous bacterial peritonitis: A retrospective study. Experimental and Therapeutic Medicine, 17(6): 4568-4576.
  • Doernberg, S.B., Lodise, T. P., Thaden, J.T., Munita, J.M., Cosgrove, S.E., Arias, C.A., Boucher, H.W., Corey, G.R., Lowy, F.D., Murray, B., Miller, L.G., Holland, T.L. and Gram-Positive Committee of the Antibacterial Resistance Leadership Group (ARLG) (2017). Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group. Clinical infectious diseases : An Official Publication of the Infectious Diseases Society of America. 64(suppl_1): S24-S29. doi: 10.1093/cid/ciw828
  • Earny, V.A., Kamath, V., Muralidharan, A., Vandana, K.E. and Khera, K. (2021). Marine microbial metabolites: A new wave of drugs for combating antimicrobial resistance. Research Journal of Pharmacy and Technology. 14(4), 2348-2352. doi: 10.52711/0974-360X.2021.00414
  • Sivalingam, P., Hong, K., Pote, J. and Prabakar, K. (2019). Extreme Environment Streptomyces: Potential Sources for New Antibacterial and Anticancer Drug Leads?. International Journal of Microbiology. 2019, 5283948. doi: 10.1155/2019/5283948
  • Montaño, E.T., Nideffer, J.F., Brumage, L., Erb, M., Busch, J., Fernandez, L., Derman, A.I., Davis, J.P., Estrada, E., Fu, S., Le, D., Vuppala, A., Tran, C., Luterstein, E., Lakkaraju, S., Panchagnula, S., Ren, C., Doan, J., Tran, S., Soriano, J. and Pogliano, J. (2022). Isolation and characterization of Streptomyces bacteriophages and Streptomyces strains encoding biosynthetic arsenals. PloS One. 17(1): e0262354. doi: 10.1371/journal.pone.0262354
  • Ashraf, N., Zafar, S., Makitrynskyy, R., Bechthold, A., Spiteller, D., Song, L., Anwar, M.A., Luzhetskyy, A., Khan, A.N., Akhtar, K. and Khaliq, S. (2022). Revealing Genome-Based Biosynthetic Potential of Streptomyces sp. BR123 Isolated from Sunflower Rhizosphere with Broad Spectrum Antimicrobial Activity. Antibiotics (Basel, Switzerland). 11(8): 1057.
  • Lee, L., Chan, K., Stach, J., Wellington, E.M. and Goh, B. (2018). Editorial: The Search for Biological Active Agent(s) From Actinobacteria. Frontiers in Microbiology. 9: Article 824.
  • Angst, D.C., Tepekule, B., Sun, L., Bogos, B. and Bonhoeffer, S. (2021). Comparing treatment strategies to reduce antibiotic resistance in an in vitro epidemiological setting. Proceedings of the National Academy of Sciences of the United States of America. 118(13): e2023467118. doi: 10.1073/pnas.2023467118
  • Mulani, M.S., Kamble, E.E., Kumkar, S.N., Tawre, M.S. and Pardesi, K.R. (2019). Emerging Strategies to Combat ESKAPE Pathogens in the Era of Antimicrobial Resistance: A Review. Frontiers in Microbiology. 10: Article 539. doi: 10.3389/fmicb.2019.00539
  • Zhanel, G.G., Mayer, M., Laing, N. and Adam, H.J. (2006). Mutant prevention concentrations of levofloxacin alone and in combination with azithromycin, ceftazidime, colistin (Polymyxin E), meropenem, piperacillin-tazobactam, and tobramycin against Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 50(6): 2228-2230. doi: 10.1128/AAC.01620-05
  • Shang, D., Liu, Y., Jiang, F., Ji, F., Wang, H., and Han, X. (2019). Synergistic antibacterial activity of designed Trp-containing antibacterial peptides in combination with antibiotics against multidrug-resistant Staphylococcus epidermidis. Frontiers in Microbiology. 10: Article 2719. doi: 10.3389/fmicb.2019.02719
  • De Cesare, G.B., Cristy, S.A., Garsin, D.A. and Lorenz, M.C. (2020). Antimicrobial Peptides: a New Frontier in Antifungal Therapy. mBio. 11(6): e02123-20.
  • Thombre, R., Jangid, K., Shukla, R. and Dutta, N.K. (2019). Editorial: Alternative Therapeutics against antimicrobial-resistant pathogens. Frontiers in Microbiology. 10: 2173. doi: 10.3389/fmicb.2019.02173
  • Peraman, R., Sure, S.K., Dusthackeer, V.N., Chilamakuru, N.B., Yiragamreddy, P.R., Pokuri, C., Kutagulla, V.K. and Chinni, S. (2021). Insights on recent approaches in drug discovery strategies and untapped drug targets against drug resistance. Future Journal of Pharmaceutical Sciences. 7(1): 1-25. doi: 10.1186/s43094-021-00196-5
  • Humphries, R., Bobenchik, A.M., Hindler, J.A. and Schuetz, A.N. (2021). Overview of Changes to the Clinical and Laboratory Standards Institute Performance Standards for Antimicrobial Susceptibility Testing, M100, 31st Edition. Journal of Clinical Microbiology, 59(12): e0021321. doi: 10.1128/JCM.00213-21
  • Viswapriya, V., and Saravana Kumari, P. (2022). Combating the emerging drug resistant Pseudomonas aeruginosa by an antibiotic purified from the novel Streptomyces violascens strain vs. Inter-national Journal of Pharm. Science & Research. 13(10): 4062-4070.
  • Huse, H.K., Lee, M.J., Wootton, M., Sharp, S.E., Traczewski, M., LiPuma, J.J. and Jorth, P. (2021). Evaluation of Antimicrobial Susceptibility Testing Methods for Burkholderia cenocepacia and Burkholderia multivorans Isolates from Cystic Fibrosis Patients. Journal of Clinical Microbiology. 59(12): e0144721. doi: 10.1128/JCM.01447-21
  • Chanda, S. and Rakholiya, K. (2011). Combination therapy: Synergism between natural plant extracts and antibiotics against infectious diseases. In: Mendez-Vilas A (ed) Science against microbial pathogens: communicating current research and technological advances. Formatex. 1: 520-529.
  • Scribner, H.E., 3rd, Tang, T. and Bradley, S.G. (1973). Production of a sporulation pigment by Streptomyces venezuelae. Applied Microbiology, 25(6): 873-879. doi: 10.1128/am.25.6.873-879.1973
  • Montaño, E.T., Nideffer, J.F., Brumage, L., Erb, M., Busch, J., Fernandez, L., Derman, A.I., Davis, J.P., Estrada, E., Fu, S., Le, D., Vuppala, A., Tran, C., Luterstein, E., Lakkaraju, S., Panchagnula, S., Ren, C., Doan, J., Tran, S. and Pogliano, J. (2022). Isolation and characterization of Streptomyces bacteriophages and Streptomyces strains encoding biosynthetic arsenals. Plos One. 17(1): e0262354. doi: 10.1371/journal.pone.0262354
  • Olanrewaju, O.S. and Babalola, O.O. (2019). Streptomyces: implications and interactions in plant growth promotion. Applied Microbiology and Biotechnology, 103(3): 1179-1188. doi: 10.1007/s00253-018-09577-y
  • Buraimoh, O.M., Ogunyemi, A.K., Isanbor, C., Aina, O.S., Amund, O.O., Ilori, M.O. and Familoni, O.B. (2021). Sustainable generation of bioethanol from sugarcane wastes by Streptomyces coelicolor strain COB KF977550 isolated from a tropical estuary. Sci. Afr. 11: e00709.
  • Kaur, T., Rani, R. and Manhas, R. K. (2019). Biocontrol and plant growth promoting potential of phylogenetically new Streptomyces sp. MR14 of rhizospheric origin. AMB Express, 9(1): 1-14. doi: 10.1186/s13568-019-0849-7
  • Baniya, A., Singh, S., Singh, M., Nepal, P., Adhikari, M., Aryal, S. and Adhikari, A. (2019). Isolation and Screening of Antibiotics Producing Streptomyces spp from the Soil Collected around the Root of Alnus nepalensis from Godawari. Nepal Journal of Biotechnology, 6(1): 46-56. doi: 10.3126/njb.v6i1.22337
  • Nagpure, A., Choudhary, B., Kumar, S., Kumar, S. and Rajinder K. Gupta. (2014). Isolation and characterization of chitinolytic Streptomyces sp. MT7 and its antagonism towards wood-rotting fungi. Ann. Microbiol. 64: 531-541. doi: 10.1007/s13213-013-0686-x
  • Uzair B., Menaa F., Khan B.A., Mohammad F.V., Ahmad V.U., Djeribi R. and Menaa B. (2018). Isolation, purification, structural elucidation and antimicrobial activities of kocumarin, a novel antibiotic isolated from actinobacterium Kocuria marina CMG S2 associated with the brown seaweed Pelvetia canaliculata. Microbiol. Res. 206: 186-197 doi: 10.1016/j.micres.2017.10.007
  • Meng, L., Sun, C., Zhang, C., Song, S., Sun, X., Ju, J. & Deng, Y. (2019). Efficacy of Compounds Isolated from Streptomyces olivaceus against the Morphogenesis and Virulence of Candida albicans. Marine Drugs. 17(8): 442. doi: 10.3390/md17080442
  • Bina, X.R., Taylor, D.L., Vikram, A., Ante, V.M. and Bina, J.E. (2013). Vibrio cholerae ToxR Downregulates Virulence Factor Production in Response to Cyclo(Phe-Pro). mBio, 4(5): e00366-13. doi: 10.1128/mBio.00366-13
  • Kapadia, C., Kachhdia, R., Singh, S., Gandhi, K., Poczai, P., Alfarraj, S., Ansari, M.J., Gafur, A. and Sayyed, R.Z. (2022). Pseudomonas aeruginosa inhibits quorum-sensing mechanisms of soft rot pathogen Lelliottia amnigena RCE to regulate its virulence factors and biofilm formation. Frontiers in Microbiology. 13: 977669. doi: 10.3389/fmicb.2022.977669
  • Roell, K.R. and Reif, D.M. (2017). An Introduction to Terminology and Methodology of Chemical Synergy-Perspectives from Across Disciplines. Frontiers in Pharmacology. 20(8): 158. doi: 10.3389/fphar.2017.00158
  • Łojewska, E. and Sakowicz, T. (2021). An Alternative to Antibiotics: Selected Methods to Combat Zoonotic Foodborne Bacterial Infections. Current Microbiology. 78(12): 4037-4049. doi: 10.1007/s00284-021-02665-9
  • Ma, J. and Motsinger-Reif, A. (2019). Current Methods for Quantifying Drug Synergism. Proteomics & Bioinformatics. 1(2): 43-48.
  • Kowalska-Krochmal, B. and Dudek-Wicher, R. (2021). The Minimum Inhibitory Concentration of Antibiotics: Methods, Interpretation, Clinical Relevance. Pathogens (Basel, Switzerland). 10(2): 165.
  • Quinn, G.A., Banat, A.M., Abdelhameed, A.M. and Banat, I.M. (2020). Streptomyces from traditional medicine: sources of new innovations in antibiotic discovery. Journal of Medical Microbiology. 69(8): 1040-1048. doi: 10.1099/jmm.0.001232

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.